Ultragenyx Pharmaceutical
RARE
$29.85
Share price
-3.90%
Change (1 day)
-40.57%
Change (1 year)
Categories
P/S ratio for Ultragenyx Pharmaceutical (RARE)
P/S ratio as of April 2025 (TTM): 5.21
According to Ultragenyx Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.1. At the end of 2024 the company had a P/S ratio of 7.16.
P/S ratio history for Ultragenyx Pharmaceutical from 2014 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 7.16 | -20.85% |
| 2023 | 9.04 | 1.15% |
| 2022 | 8.94 | -45.19% |
| 2021 | 16.3 | -51.73% |
| 2020 | 33.8 | 41.86% |
| 2019 | 23.8 | -44.54% |
| 2018 | 42.9 | -94.32% |
| 2017 | 756 | -96.5% |
| 2016 | > 1000 | |
| 2015 | N/A | |
| 2014 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 3.74 | -28.23% | 🇺🇸 USA |
 | 3.91 | -24.93% | 🇺🇸 USA |
 | 0.6311 | -87.88% | 🇺🇸 USA |
 | 5.83 | 11.95% | 🇺🇸 USA |